• 1
    Guo Y, Wang M, Zheng GS, Li WK, Kawaoka Y, Webster RG. Seroepidemiological and molecular evidence for the presence of two H3N8 equine influenza viruses in China in 1993–94. J Gen Virol 1995; 76(Pt 8):20092014.
  • 2
    Powell DG, Watkins KL, Li PH, Shortridge KF. Outbreak of equine influenza among horses in Hong Kong during 1992. Vet Rec 1995; 136:531536.
  • 3
    Yamanaka T, Niwa H, Tsujimura K, Kondo T, Matsumura T. Epidemic of equine influenza among vaccinated racehorses in Japan in 2007. J Vet Med Sci 2008; 70:623625.
  • 4
    Virmani N, Bera BC, Singh BK et al. Equine influenza outbreak in India (2008–09): virus isolation, sero-epidemiology and phylogenetic analysis of HA gene. Vet Microbiol 2010; 143:224237.
  • 5
    Yondon M, Heil GL, Burks JP et al. Isolation and characterization of H3N8 equine influenza A virus associated with the 2011 epizootic in Mongolia. Influenza Other Respi Viruses 2013; 5:659665.
  • 6
    Guthrie AJ, Stevens KB, Bosman PP. The circumstances surrounding the outbreak and spread of equine influenza in South Africa. Rev Sci Tech 1999; 18:179185.
  • 7
    King EL, Macdonald D. Report of the Board of Inquiry appointed by the Board of the National Horseracing Authority to conduct enquiry into the causes of the equine influenza which started in the Western cape in early December 2003 and spread to the Eastern Cape and Gauteng. Aust Equine Vet 2004; 23:139142.
  • 8
    Garner MG, Cowled B, East IJ, Moloney BJ, Kung NY. Evaluating the effectiveness of early vaccination in the control and eradication of equine influenza–a modelling approach. Prev Vet Med 2011; 99:1527.
  • 9
    Sovinova O, Tumova B, Pouska F, Nemec J. Isolation of a virus causing respiratory disease in horses. Acta Virol 1958; 2:5261.
  • 10
    Webster RG. Are equine 1 influenza viruses still present in horses? Equine Vet J 1993; 25:537538.
  • 11
    OIE Bulletin. Expert surveillance panel of equine influenza vaccines – conclusions and recommendations. Mill Hill, London, United Kingdom, 2008; 4245.
  • 12
    Willoughby R, Ecker G, McKee S et al. The effects of equine rhinovirus, influenza virus and herpesvirus infection on tracheal clearance rate in horses. Can J Vet Res 1992; 56:115121.
  • 13
    Cullinane A, Newton JR. Equine influenza-A global perspective. Vet Microbiol 2013; doi: 10.1016/j.vetmic.2013.03.029.
  • 14
    Gross DK, Hinchcliff KW, French PS et al. Effect of moderate exercise on the severity of clinical signs associated with influenza virus infection in horses. Equine Vet J 1998; 30:489497.
  • 15
    Christley RM, French NP. Small-world topology of UK racing: the potential for rapid spread of infectious agents. Equine Vet J 2003; 35:586589.
  • 16
    Newton JR, Daly JM, Spencer L, Mumford JA. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease. Vet Rec 2006; 158:185192.
  • 17
    Cullinane A. Equine influenza – a constantly evolving challenge. Equine Vet Educ 2009; 8:17.
  • 18
    Livesay GJ, O'Neill T, Hannant D, Yadav MP, Mumford JA. The outbreak of equine influenza (H3N8) in the United Kingdom in 1989: diagnostic use of an antigen capture ELISA. Vet Rec 1993; 133:515519.
  • 19
    Newton JR, Verheyen K, Wood JL, Yates PJ, Mumford JA. Equine influenza in the United Kingdom in 1998. Vet Rec 1999; 145:449452.
  • 20
    Gildea S, Arkins S, Cullinane A. Management and environmental factors involved in equine influenza outbreaks in Ireland 2007–2010. Equine Vet J 2011; 43:608617.
  • 21
    Quinlivan M, Dempsey E, Ryan F, Arkins S, Cullinane A. Real-time reverse transcription PCR for detection and quantitative analysis of equine influenza virus. J Clin Microbiol 2005; 43:50555057.
  • 22
    OIE. Manual of Standards for Diagnostics Tests and Vaccines, Equine Influenza. Chapter 2.5.7, Paris: OIE, 2012; 114.
  • 23
    Gildea S, Arkins S, Cullinane A. A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus. Influenza Other Respi Viruses 2010; 4:363372.
  • 24
    Newton JR, Townsend HG, Wood JL, Sinclair R, Hannant D, Mumford JA. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Vet J 2000; 32:6574.
  • 25
    Gildea S, Quinlivan M, Arkins S, Cullinane A. The molecular epidemiology of equine influenza in Ireland from 2007–2010 and its international significance. Equine Vet J 2012; 44:387392.
  • 26
    Larkin MA, Blackshields G, Brown NP et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007; 23:29472948.
  • 27
    Keane TM, Creevey CJ, Pentony MM, Naughton TJ, McLnerney JO. Assessment of methods for amino acid matrix selection and their use on empirical data shows that ad hoc assumptions for choice of matrix are not justified. BMC Evol Biol 2006; 6:29.
  • 28
    Hasegawa M, Kishino H, Yano T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 1985; 22:160174.
  • 29
    Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003; 52:696704.
  • 30
    Ha Y, Stevens DJ, Skehel JJ, Wiley DC. X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus. Virology 2003; 309:209218.
  • 31
    Bryant NA, Rash AS, Russell CA et al. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007. Vet Microbiol 2009; 138:4152.
  • 32
    Bryant NA, Rash AS, Woodward AL et al. Isolation and characterisation of equine influenza viruses (H3N8) from Europe and North America from 2008 to 2009. Vet Microbiol 2011; 147:1927.
  • 33
    Qi T, Guo W, Huang WQ et al. Genetic evolution of equine influenza viruses isolated in China. Arch Virol 2010; 155:14251432.
  • 34
    Lai AC, Chambers TM, Holland RE Jr et al. Diverged evolution of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere. Arch Virol 2001; 146:10631074.
  • 35
    Morley PS, Townsend HG, Bogdan JR, Haines DM. Risk factors for disease associated with influenza virus infections during three epidemics in horses. J Am Vet Med Assoc 2000; 216:545550.
  • 36
    Callinan I. The August 2007 outbreak in Australia: Commonwealth of Australia. Available at (Accessed 12th June 2008).
  • 37
    Mumford JA, Jessett D, Dunleavy U et al. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. Vaccine 1994; 12:857863.
  • 38
    Mumford JA, Wilson H, Hannant D, Jessett DM. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiol Infect 1994; 112:421437.
  • 39
    Wood JLN. A review of the history and epidemiology and a description of recent outbreak. MSc Dissertation. London: University of London, 1991.
  • 40
    Mumford JA. Biology, epidemiology and vaccinology of equine influenza. Proceedings of the International Symposium, Budapest, 10–11 December 2001; 712.
  • 41
    Gildea S, Arkins S, Walsh C, Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings–a randomised blind study. Vaccine 2011; 29:92149223.
  • 42
    Gildea S, Quinlivan M, Murphy BA, Cullinane A. Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings - A blinded comparison of commercially available vaccines. Vaccine 2013; in press doi: 10.1016/j.vaccine.2013.08.083.
  • 43
    Cullinane A, Weld J, Osborne M, Nelly M, McBride C, Walsh C. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings. Vet J 2001; 161:174185.
  • 44
    Heldens JG, Kersten AJ, Weststrate MW, van den Hoven R. Duration of immunity induced by an adjuvanted and inactivated equine influenza, tetanus and equine herpesvirus 1 and 4 combination vaccine. Vet Q 2001; 23:210217.
  • 45
    Daly JM, Yates RJ, Browse G et al. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines. Equine Vet J 2003; 35:458462.
  • 46
    Gildea S, Arkins S, Walsh C, Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses – a randomised blind study. Vaccine 2011; 29:39173922.